Literature DB >> 18595657

Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse.

Barbara D Abbott1, Cynthia J Wolf2, Kaberi P Das2, Robert D Zehr2, Judith E Schmid2, Andrew B Lindstrom3, Mark J Strynar3, Christopher Lau2.   

Abstract

Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) are members of a family of perfluorinated compounds. Both are environmentally persistent and found in the serum of wildlife and humans. PFOS and PFOA are developmentally toxic in laboratory rodents. Exposure to these chemicals in utero delays development and reduces postnatal survival and growth. Exposure to PFOS on the last 4 days of gestation in the rat is sufficient to reduce neonatal survival. PFOS and PFOA are weak agonists of peroxisome proliferator activated receptor-alpha (PPAR alpha). The reduced postnatal survival of neonatal mice exposed to PFOA was recently shown to depend on expression of PPAR alpha. This study used PPAR alpha knockout (KO) and 129S1/SvlmJ wild type (WT) mice to determine if PPAR alpha expression is required for the developmental toxicity of PFOS. After mating overnight, the next day was designated gestation day (GD) 0. WT females were weighed and dosed orally from GD15 to 18 with 0.5% Tween-20, 4.5, 6.5, 8.5, or 10.5mg PFOS/kg/day. KO females were dosed with 0.5% Tween-20, 8.5 or 10.5mg PFOS/kg/day. Dams and pups were observed daily and pups were weighed on postnatal day (PND) 1 and PND15. Eye opening was recorded from PND12 to 15. Dams and pups were killed on PND15, body and liver weights recorded, and serum collected. PFOS did not affect maternal weight gain or body or liver weights of the dams on PND15. Neonatal survival (PND1-15) was significantly reduced by PFOS in both WT and KO litters at all doses. WT and KO pup birth weight and weight gain from PND1 to 15 were not significantly affected by PFOS exposure. Relative liver weight of WT and KO pups was significantly increased by the 10.5mg/kg dose. Eye opening of PFOS-exposed pups was slightly delayed in WT and KO on PND13 or 14, respectively. Because results in WT and KO were comparable, it is concluded that PFOS-induced neonatal lethality and delayed eye opening are not dependent on activation of PPAR alpha.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18595657     DOI: 10.1016/j.reprotox.2008.05.061

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  26 in total

1.  Developmental toxicology: new directions workshop: refining testing strategies and study designs.

Authors:  Kimberly C Brannen; Suzanne E Fenton; Deborah K Hansen; Wafa Harrouk; James H Kim; Dana Shuey
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2011-10

2.  Environmental and biological monitoring of persistent fluorinated compounds in Japan and their toxicities.

Authors:  Kouji H Harada; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2008-11-11       Impact factor: 3.674

3.  Paradoxical Protective Effect of Perfluorooctanesulfonic Acid Against High-Fat Diet-Induced Hepatic Steatosis in Mice.

Authors:  Ian Huck; Kevin Beggs; Udayan Apte
Journal:  Int J Toxicol       Date:  2018-08-22       Impact factor: 2.032

4.  Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability.

Authors:  Yong Qian; Alan Ducatman; Rebecca Ward; Steve Leonard; Valerie Bukowski; Nancy Lan Guo; Xianglin Shi; Val Vallyathan; Vincent Castranova
Journal:  J Toxicol Environ Health A       Date:  2010

Review 5.  Why toxic equivalency factors are not suitable for perfluoroalkyl chemicals.

Authors:  Jeffrey M Peters; Frank J Gonzalez
Journal:  Chem Res Toxicol       Date:  2011-09-28       Impact factor: 3.739

6.  Human serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in Uyghurs from Sinkiang-Uighur Autonomous Region, China: background levels study.

Authors:  Xiao-Wen Zeng; Zhengmin Qian; Michael Vaughn; Hong Xian; Keith Elder; Eugene Rodemich; Jia Bao; Yi-He Jin; Guang-Hui Dong
Journal:  Environ Sci Pollut Res Int       Date:  2014-10-23       Impact factor: 4.223

7.  The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo.

Authors:  D K Coletta; M Fernandez; E Cersosimo; A Gastaldelli; N Musi; R A DeFronzo
Journal:  Diabet Med       Date:  2015-01-07       Impact factor: 4.359

8.  Developmental effects of perfluorononanoic Acid in the mouse are dependent on peroxisome proliferator-activated receptor-alpha.

Authors:  Cynthia J Wolf; Robert D Zehr; Judy E Schmid; Christopher Lau; Barbara D Abbott
Journal:  PPAR Res       Date:  2010-09-27       Impact factor: 4.964

9.  Gene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent Effects.

Authors:  Mitchell B Rosen; Judith R Schmid; J Christopher Corton; Robert D Zehr; Kaberi P Das; Barbara D Abbott; Christopher Lau
Journal:  PPAR Res       Date:  2010-09-27       Impact factor: 4.964

10.  Model and cell membrane partitioning of perfluorooctanesulfonate is independent of the lipid chain length.

Authors:  Wei Xie; Gabriele Ludewig; Kai Wang; Hans-Joachim Lehmler
Journal:  Colloids Surf B Biointerfaces       Date:  2009-10-27       Impact factor: 5.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.